HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

Watanabe Y, Tokunaga K, Matsuki K, Takeuchi F, Matsuta K, Maeda H, et al. Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility. J Exp Med 1989; 169: 2263-8.

Vogt A. Fruhezeitiges Ergaven der Zilien und Bemerkungen uber den sogennanten plotzlichen Entritt dieser Veranderung. KlinMonastsblAugenheilkd 1906; 45:228-42.

Koyanagi Y. Dysakuisis, Alopecia und Poliosis bei schwerer Uveitis nichit traumatischen Ursprungs. Klin Monastbl Augenheilkd 1929; 82: 194-211.

Harada Y, Beitrag zur Klinischen Keutuis von michteitriger Choroiditis (choroiditis diffusa acta). Acta Ophthalmol Jpn 1926; 30: 356-78.

Sugiura S. Vogt-Koyanagi-Harada disease. Jpn Ophthalmol 1978; 22:9-35.

Ohno S. Immunological aspects of Behcet's and Vogt- Koyanagi-Harada's diseases. Trans Ophthalmol Soc UK 1981; 101:335-41.

Ohno S. Vogt-Koyanagi-Harada's disease. In: Sarri KM, ed. Uveitis update. Amsterdam: Elsevier, 1984: 401-5.

Zhao M, Jiang Y, Abrahams W. Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Arch Ophthalmol 1991; 109: 368-70.

Inoko H. PCR-RFLP method holds great promise for complete HLA class II genotyping. TissueAntigens 1990; 36: 88-92.

PetesdorfEW, Smith AG, Mickelson EM, Martin PJ, Hansen JA. Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain. Immunogenetics 1990; 33: 267-75.

Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1991. TissueAntigens 1991; 37: 181-9.

Terasaki PI, Mac Cell. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998-1000.

OtaM, Seki T, Fukushima H, Tsuji K, Inoko H. HLA DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1992; 39: 187-202.

Bachelor JR, MacMicheal AJ. Progress in understanding HLA and disease associations. Br Med Bull 1987; 43: 156-83.

Brown JH,Jardetzky T, Saper MA, Samraoui B, Bjorkman PJ, Wiley DC. A hypothetical model of the foreign antigen binding site of classII histocompatibility molecules. Nature 1988; 332: 845-50.

Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506-12.

Lanchbury JSS, Hall MA, Welsh KI, Panayi GS. Sequence analysis of HLA-DR4B1 subtypes: additional first domain variability is detected by oligonucleotide hybridization and nucleotide sequencing. Hum Immunol 1990; 27: 136-44.

Ohno S, Char DH, Kimura SJ, O'Conner GR. Vogt- Koyanagi-Harada syndrome. Am J Ophthalmol 1977; 83: 735-40.

Korman AJ, Bass JM, Spies T, Sorrentino R, Okada K, Strominger JL. Genetic complexity and expression of human class II histocompatibility antigens. Immunol Rev 1985; 85:45-86.